Lee Ainslie Agilent Technologies, Inc. Transaction History

Maverick Capital LTD

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$101.17 - $139.82 $850,536 - $1.18 Million	8,407 Added 264.54%	11,585 $1.61 Million
Q3 2023 Nov 14, 2023	BUY	$109.73 - $128.47 $348,721 - $408,277	3,178 New	3,178 $355,000
Q4 2021 Feb 14, 2022	SELL	$147.95 - $164.3 $1.86 Million - $2.06 Million	-12,539 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$147.58 - $179.28 $1.85 Million - $2.25 Million	12,539 New	12,539 $1.98 Million
Q3 2020 Nov 16, 2020	SELL	$88.11 - $103.42 $2.2 Million - $2.58 Million	-24,985 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$68.92 - $91.14 $2 Million - $2.64 Million	-29,007 Reduced 53.72%	24,985 $2.21 Million
Q1 2020 May 15, 2020	BUY	$63.37 - $90.13 $3.42 Million - $4.87 Million	53,992 New	53,992 $3.87 Million
Q2 2018 Aug 14, 2018	SELL	$61.14 - $69.55 $1.87 Million - $2.12 Million	-30,520 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$65.05 - $74.82 $1.99 Million - $2.28 Million	30,520 New	30,520 $2.04 Million

1,148

252M

729K

970K

Ticker A
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 296,040,992
Market Cap $39.6B
Description
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatogra...

Get notified when there are updates to the investment portfolio of Maverick Capital LTD, based on Form 13F filings with the SEC.

Stay updated on Maverick Capital LTD and Lee Ainslie with notifications on news.